期刊文献+

丹红注射液联合厄贝沙坦对糖尿病肾病患者氧化应激反应、肾功能损害的影响 被引量:8

Effect of Danhong injection combined with irbesartan on oxidative stress and renal function damage in patients with diabetic nephropathy
下载PDF
导出
摘要 目的:研究丹红注射液联合厄贝沙坦对糖尿病肾病患者氧化应激反应、肾功能损害的影响。方法:选择在本院接受治疗的糖尿病肾病患者,采用随机数表法分为丹红+ARB组和ARB组,分别常规降糖+丹红注射液+厄贝沙坦治疗以及常规降糖+厄贝沙坦治疗。治疗前和治疗后6周时,检测两组血清中肾功能生化指标、血小板活化指标、氧化应激指标的含量。结果:治疗后,两组患者血清中BUN、Cr、β2-MG、Cys-C、PECAM-1、CD62p、PAC-1、MDA、8-OHdG、8-iso-PGF2a的含量较治疗前显著降低,T-AOC、Cu-Zn-SOD、Mn-SOD、GPx-1的含量较治疗前显著升高(P<0.05)且丹红+ARB组患者治疗后血清中BUN、Cr、β2-MG、Cys-C、PECAM-1、CD62p、PAC-1、MDA、8-OHdG、8-iso-PGF2a的含量显著低于ARB组,T-AOC、Cu-Zn-SOD、Mn-SOD、GPx-1的含量显著高于ARB组。结论:丹红注射液联合厄贝沙坦治疗糖尿病肾病能够减轻肾功能损害、改善氧化应激反应。 Objective: To study the effect of Danhong injection combined with irbesartan on oxidative stress and renal function damage in patients with diabetic nephropathy. Methods= Patients with diabetic nephropathy who were treated in hospi- tal of Minzu University of China were selected, and random number table was used to divide them into Danhong + ARB group and ARB group who received routine hypoglycemic + Danhong injection + irbesartan therapy and routine hypoglycemic + irbesartan therapy respectively. The serum levels of renal function biochemical indexes, platelet activation indexes and oxidative stress indexes of the two groups of patients were detected before and 6 weeks after treatment. Results: After treatment, serum BUN, Cr,β2-MG, Cys-C, PECAM-1, CD62p, PAC-1, MDA, 8-OHdG and 8-iso-PGF2a levels of both groups of patients were significantly lower than those before treatment while T-AOC, Cu-Zn-SOD, Mn-SOD and GPx-1 levels were significantly higher than those before treatment (P〈Z0.05) and serum BUN, Cr, 132-MG, Cys-C, PECAMq, CD62p, PAC-1, MDA, 8- OHdG and 8-iso-PGF2a levels of Danhong + ARB group after treatment were significantly lower than those of ARB group while T-AOC, Cu-Zn-SOD, Mn-SOD and GPx-1 levels were significantly higher than those of ARB group. Conclusions: Dan- hong injection combined with irbesartan therapy for diabetic nephropathy can reduce renal function damage and improve oxida- tive stress response.
出处 《海南医学院学报》 CAS 2017年第15期2052-2055,共4页 Journal of Hainan Medical University
基金 北京市卫生局专项基金
关键词 糖尿病肾病 丹红 厄贝沙坦 血小板活化 氧化应激反应 Diabetic nephropathy Danhong irbesartan Platelet activation Oxidative stress response
  • 相关文献

参考文献1

二级参考文献22

  • 1Gowdak LH, Arantes RL, de Paula FJ, et al. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients [J]. Ren Fail, 2007, 29 (5): 559-565.
  • 2Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study [J]. Clin J Am Soc Nephml, 2006, 1 (4) : 761 - 767.
  • 3Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease [ J ]. J Intern Med, 2010, 268 (5): 456-467.
  • 4Reutens AT, Atkins RC. Epidcmiology of diabetic nephropathy [ J ]. Contrib Nephrol, 2011, 170: 1-7.
  • 5Tang SC. Diabetic nephropathy: a global and growing threat [ J ]. Hong Kong Med J, 2010, 16 (4) : 244 -245.
  • 6WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications [ Z ] . Geneva: WHO, 1999.
  • 7Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2003, 26 (1) : s5 -20.
  • 8American Diabetes Association. Diagnosis and classification of diabetes mellitus [J]. Diabetes Care , 2012, 35 (1): 64-71.
  • 9American Diabetes Association. Standards of medical care in diabetes [J]. Diabetes Care, 2011, 34 (1): 11-61.
  • 10National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification [J]. Am J Kidney Dis, 2002, 39 (2 suppl 1) : 1 -266.

共引文献18

同被引文献107

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部